UPSHER SMITH LABS FDA Approval ANDA 072879

ANDA 072879

UPSHER SMITH LABS

FDA Drug Application

Application #072879

Application Sponsors

ANDA 072879UPSHER SMITH LABS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL150MG0AMOXAPINEAMOXAPINE

FDA Submissions

ORIG1AP1991-06-28
LABELING; LabelingSUPPL2AP1993-07-29
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1994-01-24
LABELING; LabelingSUPPL4AP1995-04-10
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1997-09-17
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1999-05-05
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2000-09-18
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2001-03-23
LABELING; LabelingSUPPL9AP2001-05-22
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2002-03-25
LABELING; LabelingSUPPL14AP2014-07-17STANDARD

Submissions Property Types

SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL10Null0
SUPPL14Null15

CDER Filings

UPSHER SMITH LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 72879
            [companyName] => UPSHER SMITH LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMOXAPINE","activeIngredients":"AMOXAPINE","strength":"150MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AMOXAPINE","submission":"AMOXAPINE","actionType":"150MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.